Trial Profile
A Phase I trial of an RNActive rabies vaccine
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 15 Jan 2018
Price :
$35
*
At a glance
- Drugs Nadorameran (Primary)
- Indications Rabies
- Focus Adverse reactions
- Sponsors CureVac
- 15 Jan 2018 New trial record
- 10 Jan 2018 According to a CureVac media release, the company will initiate this trial in 2018.